2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Temporal course of the total motor score in Huntington disease

P. Auinger, T.J. Felong, S. Gandhi, V. Abler, K. Biglan, S. Papapetropoulos, C. Venuto, R. Dorsey (Rochester, NY, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Temporal course of the UHDRS chorea score in Huntington disease

T.J. Felong, P. Auinger, S. Gandhi, V. Abler, K. Biglan, S. Papapetropoulos, C. Venuto, R. Dorsey (Rochester, NY, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Temporal working memory deficit in Parkinson’s disease

B. Degos, I. Ameqrane, S. Rivaud-Péchoux, P. Pouget, M. Missal (Paris, France)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Testing candidate transcriptional biomarkers of asymtpomatic and symptomatic stages in spinocerebellar ataxia type 3 (SCA3)

M. Raposo, C. Bettencourt, M. Lima (Ponta Delgada, Portugal)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The aetiology of idiopathic late onset cerebellar ataxia

R. Barbosa, M. Mendonça, T. Lampreia, P. Bugalho (Lisboa, Portugal)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The alterations in behavioral memory for prolongation disease duration in patients with Parkinson’s disease

M. Saruwatari, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara, Japan)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The assessment of quality of life in patients with early and moderately advanced Huntington disease

N. Szejko, L. Milanowski, A. Gogol, Z. Jamrozik, P. Janik (Warsaw, Poland)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach

F. Rahmani, M.H. Aarabi (Tehran, Islamic Republic of Iran)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease

F. Imperiale, F. Agosta, E. Canu, V. Špica, M. Jecmenica, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2